Tuesday, July 23, 2024
WebStore.pk Banner
HomeAviationNeuralink Implant Allows First Patient to Control Computer Mouse with Brain Activity.

Neuralink Implant Allows First Patient to Control Computer Mouse with Brain Activity.

Elon Musk, the founder of Neuralink, claims that the first individual to have a brain chip implanted by the business appears to have recovered and is able to use their thoughts to control a computer mouse. “The patient is making good progress and appears to have fully recovered, with no side effects that we are aware of.” “Patients can navigate the screen with a mouse just by thinking,” Musk stated on his social media platform X late on Monday during a Spaces event.

This past month, Musk posted on social media that the business had implanted a chip in its first human patient back in January.

In September, the business said that U.S. regulators had given it permission to begin recruiting human subjects for the experiment. The startup’s primary goal is to use its technology to enable people with catastrophic injuries to operate computers with only their thoughts.

The first patient’s name is unknown, but Neuralink announced last year that it was looking for people for its studies who have quadriplegia from either amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease or cervical spinal cord injury.

According to Neuralink, the present study entailed implanting a brain-computer interface in a region of the brain that transmits movement intention.

Earlier this month, the nonpartisan research organization Hastings Center released a blog post criticizing Neuralink’s method of information distribution as “science by press release.” In a statement, the center stated that it thought “an unprecedented experiment involving a vulnerable person” ought to be publicly reported.

University of Pennsylvania ethicists argue that relying solely on information from a financially invested party compromises basic ethical standards in human experiments.

Although early feasibility studies of medical devices are not required to be reported to the Food and Drug Administration, the surgeons, neuroscientists, and nurses involved in the trial have an ethical obligation to provide transparency. Moreno and Caplan are also included.

Experts emphasize the importance of ethical transparency for companies developing brain-computer interfaces, even with complex technical regulations. They warn against raising false hopes for individuals with neurological disabilities.

Neuralink has not yet responded.


Most Popular

Recent Comments